<p>隨着亞洲市場在科技行業的樂觀情緒和不斷變化的經濟政策中不斷前行，投資者密切關注與這些趨勢相符的增長機會。在這種背景下，擁有高內部持股的公司往往成為潛在的增長候選者，因為這可能表明與企業關係最密切的人對其強烈信心。</p>
<h3>亞洲高內部持股的十大增長公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>盈利增長</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>JV Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們篩選的 623 只高內部持股快速增長的亞洲公司的完整名單。</p>
<p>讓我們回顧一些我們篩選股票中的顯著選擇。</p>
<h2>ROBOTIS (KOSDAQ:A108490)</h2>
<p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> ROBOTIS 有限公司在韓國提供機器人解決方案，市值為 39.1 億韓元。</p>
<p><strong>運營：</strong> 該公司通過開發、製造和銷售個人機器人產生 341.1 億韓元的收入。</p>
<p><strong>內部持股：</strong> 24.2%</p>
<p><strong>盈利增長預測：</strong> 每年 90.8%。</p>
<p>ROBOTIS 展現出顯著的增長潛力，今年實現盈利，預計盈利將以每年 90.8% 的速度大幅增長，超過韓國市場平均水平。收入也預計將以每年 51.9% 的速度快速增長。儘管最近股價波動劇烈，但該公司在最新的盈利結果中報告了從虧損到盈利的顯著轉變，並完成了一筆約 2098.5 億韓元的後續股權發行，增強了其未來擴張的財務狀況。</p>
<ul>
<li>在我們的盈利增長報告中更詳細地瞭解 ROBOTIS 的潛力。</li>
<li>我們的綜合估值報告提出 ROBOTIS 的當前價格可能高於其財務狀況所能合理支持的水平。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="1048" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth"/></p>
<p>KOSDAQ:A108490 截至 2026 年 1 月的盈利和收入增長</p>
<h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
<p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> SBT Ultrasonic Technology 有限公司專注於全球超聲設備的研究、開發、設計、生產和銷售，市值為 162.7 億人民幣。</p>
<p><strong>運營：</strong> 該公司的收入主要來自其機械與工業設備部門，產生了 6.9691 億人民幣的收入。</p>
<p><strong>內部持股：</strong> 21.2%</p>
<p><strong>盈利增長預測：</strong> 每年 37.1%。</p>
<p>SBT Ultrasonic Technology 展現出令人印象深刻的增長，2025 年前九個月的盈利飆升至 9403 萬人民幣，較去年同期的 2045 萬人民幣大幅增長。收入從 4.0817 億人民幣增加至 5.2052 億人民幣。儘管最近股價波動劇烈，預測顯示其收入和盈利增長分別超過市場平均水平，達到 32.5% 和 37.1% 的年增長率，突顯其在亞洲競爭激烈的市場中的強勁增長軌跡。</p>
<ul>
<li>點擊探索我們在 SBT Ultrasonic Technology 盈利增長報告中的詳細發現。</li>
<li>我們編制的估值報告表明，SBT Ultrasonic Technology 當前的價格可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="636" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown"/></p>
<p>SHSE:688392 截至 2026 年 1 月的持股結構</p>
<h2>Winning Health Technology Group (SZSE:300253)</h2>
<p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Winning Health Technology Group 有限公司為中國的醫療和健康機構提供數字健康服務，市值為 306.9 億人民幣。</p>
<p><strong>運營：</strong> Winning Health Technology Group 有限公司通過為中國各地的醫療和健康機構提供量身定製的數字健康服務來產生收入。</p>
<p><strong>內部持股：</strong> 22.2%</p>
<p><strong>盈利增長預測：</strong> 每年 76.7%。</p>
<p>Winning Health Technology Group 的交易價格顯著低於其估計的公允價值，表明潛在的低估。儘管在 2025 年前九個月出現了 2.4139 億人民幣的淨虧損，但預計該公司將在三年內實現盈利，收入年增長預計為 20.3%，超過市場平均水平。然而，投資者應注意股價波動較大，預測的股本回報率為 7.8%。</p>
<ul>
<li>在這裏深入瞭解 Winning Health Technology Group 的具體情況，查看我們的詳細增長預測報告。</li>
<li>我們的估值報告顯示 Winning Health Technology Group 可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="1642" height="1048" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300253 截至 2026 年 1 月的盈利和收入增長</p>
<h2>抓住機會</h2>
<ul>
<li>在這裏探索我們篩選的 623 個高內部持股快速增長的亞洲公司。</li>
<li>對其他選擇感興趣？尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
<p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有引用的預測收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>

衞寧健康

鋭明技術

<p>隨着亞洲市場在科技樂觀情緒中蓬勃發展，擁有高內部持股的公司正吸引投資者的關注。值得注意的公司包括 UTI、鋭明技術和 Phison Electronics，展現出顯著的盈利增長。ROBOTIS 的內部持股比例為 24.2%，預計年盈利增長達到 90.8%，而 SBT 超聲波技術預計為 37.1%。儘管衞寧健康近期出現虧損，但預計在三年內實現盈利，增長預測為 76.7%。這些公司突顯了亞洲不斷發展的經濟格局中的潛在增長機會</p>

<p>As Asian markets continue to navigate a landscape marked by optimism in the tech sector and evolving economic policies, investors are keenly observing growth opportunities that align with these trends. In this context, companies with high insider ownership often stand out as potential candidates for growth, as they may indicate strong confidence from those closest to the business.</p>
<div class="lb-trans"><p>隨着亞洲市場在科技行業的樂觀情緒和不斷變化的經濟政策中不斷前行，投資者密切關注與這些趨勢相符的增長機會。在這種背景下，擁有高內部持股的公司往往成為潛在的增長候選者，因為這可能表明與企業關係最密切的人對其強烈信心。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亞洲高內部持股的十大增長公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>內部持股</strong></td>
<td><strong>盈利增長</strong></td>
</tr>
<tr>
<td>UTI (KOSDAQ:A179900)</td>
<td>24.7%</td>
<td>120.7%</td>
</tr>
<tr>
<td>Streamax Technology (SZSE:002970)</td>
<td>32.5%</td>
<td>33.1%</td>
</tr>
<tr>
<td>Phison Electronics (TPEX:8299)</td>
<td>10.8%</td>
<td>31.7%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>31.4%</td>
</tr>
<tr>
<td>Loadstar Capital K.K (TSE:3482)</td>
<td>31%</td>
<td>23.6%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>34.8%</td>
<td>34.2%</td>
</tr>
<tr>
<td>JV Energy Technology (TWSE:6869)</td>
<td>17.9%</td>
<td>31.6%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>37.5%</td>
</tr>
<tr>
<td>FUNDINNOInc (TSE:462A)</td>
<td>34.4%</td>
<td>41.5%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>10.6%</td>
<td>55.2%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 623 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們篩選的 623 只高內部持股快速增長的亞洲公司的完整名單。</p>
</div><p>Let's review some notable picks from our screened stocks.</p>
<div class="lb-trans"><p>讓我們回顧一些我們篩選股票中的顯著選擇。</p>
</div><h2>ROBOTIS (KOSDAQ:A108490)</h2>
<div class="lb-trans"><h2>ROBOTIS (KOSDAQ:A108490)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> ROBOTIS Co., Ltd. offers robotic solutions in South Korea and has a market cap of ₩3.91 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> ROBOTIS 有限公司在韓國提供機器人解決方案，市值為 39.1 億韓元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of ₩34.11 billion from developing, manufacturing, and selling personal robots.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司通過開發、製造和銷售個人機器人產生 341.1 億韓元的收入。</p>
</div><p><strong>Insider Ownership:</strong> 24.2%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 24.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 90.8% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 每年 90.8%。</p>
</div><p>ROBOTIS has demonstrated significant growth potential, becoming profitable this year with earnings forecasted to grow substantially at 90.8% per year, outpacing the KR market average. Revenue is also expected to increase rapidly by 51.9% annually. Despite a highly volatile share price recently, the company reported a notable swing from loss to profit in its latest earnings results and completed a follow-on equity offering worth approximately ₩209.85 billion, enhancing its financial position for future expansion.</p>
<div class="lb-trans"><p>ROBOTIS 展現出顯著的增長潛力，今年實現盈利，預計盈利將以每年 90.8% 的速度大幅增長，超過韓國市場平均水平。收入也預計將以每年 51.9% 的速度快速增長。儘管最近股價波動劇烈，但該公司在最新的盈利結果中報告了從虧損到盈利的顯著轉變，並完成了一筆約 2098.5 億韓元的後續股權發行，增強了其未來擴張的財務狀況。</p>
</div><ul>
<li>Take a closer look at ROBOTIS' potential here in our earnings growth report.</li>
<li>Our comprehensive valuation report raises the possibility that ROBOTIS is priced higher than what may be justified by its financials.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我們的盈利增長報告中更詳細地瞭解 ROBOTIS 的潛力。</li>
<li>我們的綜合估值報告提出 ROBOTIS 的當前價格可能高於其財務狀況所能合理支持的水平。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/8599c66c-4e60-4884-8033-dd38411ddd2a/chart/earnings-and-revenue-growth"/></p>
<p>KOSDAQ:A108490 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>KOSDAQ:A108490 截至 2026 年 1 月的盈利和收入增長</p>
</div><h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
<div class="lb-trans"><h2>SBT Ultrasonic Technology (SHSE:688392)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> SBT Ultrasonic Technology Co., Ltd. focuses on the research, development, design, production, and sale of ultrasonic equipment globally and has a market cap of CN¥16.27 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> SBT Ultrasonic Technology 有限公司專注於全球超聲設備的研究、開發、設計、生產和銷售，市值為 162.7 億人民幣。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Machinery &amp; Industrial Equipment segment, which generated CN¥696.91 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自其機械與工業設備部門，產生了 6.9691 億人民幣的收入。</p>
</div><p><strong>Insider Ownership:</strong> 21.2%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 21.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 37.1% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 每年 37.1%。</p>
</div><p>SBT Ultrasonic Technology has shown impressive growth, with earnings soaring to CNY 94.03 million for the first nine months of 2025, up from CNY 20.45 million a year ago. Revenue increased to CNY 520.52 million from CNY 408.17 million over the same period. Despite recent share price volatility, forecasts suggest robust revenue and earnings growth exceeding market averages at 32.5% and 37.1% annually respectively, underscoring its strong growth trajectory in Asia's competitive landscape.</p>
<div class="lb-trans"><p>SBT Ultrasonic Technology 展現出令人印象深刻的增長，2025 年前九個月的盈利飆升至 9403 萬人民幣，較去年同期的 2045 萬人民幣大幅增長。收入從 4.0817 億人民幣增加至 5.2052 億人民幣。儘管最近股價波動劇烈，預測顯示其收入和盈利增長分別超過市場平均水平，達到 32.5% 和 37.1% 的年增長率，突顯其在亞洲競爭激烈的市場中的強勁增長軌跡。</p>
</div><ul>
<li>Click to explore a detailed breakdown of our findings in SBT Ultrasonic Technology's earnings growth report.</li>
<li>The valuation report we've compiled suggests that SBT Ultrasonic Technology's current price could be inflated.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊探索我們在 SBT Ultrasonic Technology 盈利增長報告中的詳細發現。</li>
<li>我們編制的估值報告表明，SBT Ultrasonic Technology 當前的價格可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/6b51e1de-cad8-4989-bd4e-a960ea55792e/chart/ownership-breakdown"/></p>
<p>SHSE:688392 Ownership Breakdown as at Jan 2026</p>
<div class="lb-trans"><p>SHSE:688392 截至 2026 年 1 月的持股結構</p>
</div><h2>Winning Health Technology Group (SZSE:300253)</h2>
<div class="lb-trans"><h2>Winning Health Technology Group (SZSE:300253)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 增長評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Winning Health Technology Group Co., Ltd. offers digital health services to medical and health institutions in China, with a market cap of CN¥30.69 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Winning Health Technology Group 有限公司為中國的醫療和健康機構提供數字健康服務，市值為 306.9 億人民幣。</p>
</div><p><strong>Operations:</strong> Winning Health Technology Group Co., Ltd. generates revenue by providing digital health services tailored for medical and health institutions across China.</p>
<div class="lb-trans"><p><strong>運營：</strong> Winning Health Technology Group 有限公司通過為中國各地的醫療和健康機構提供量身定製的數字健康服務來產生收入。</p>
</div><p><strong>Insider Ownership:</strong> 22.2%</p>
<div class="lb-trans"><p><strong>內部持股：</strong> 22.2%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 76.7% p.a.</p>
<div class="lb-trans"><p><strong>盈利增長預測：</strong> 每年 76.7%。</p>
</div><p>Winning Health Technology Group is trading significantly below its estimated fair value, indicating potential undervaluation. Despite a recent net loss of CNY 241.39 million for the first nine months of 2025, the company is expected to achieve profitability within three years with revenue growth projected at 20.3% annually, surpassing market averages. However, investors should note the high share price volatility and low forecasted return on equity of 7.8%.</p>
<div class="lb-trans"><p>Winning Health Technology Group 的交易價格顯著低於其估計的公允價值，表明潛在的低估。儘管在 2025 年前九個月出現了 2.4139 億人民幣的淨虧損，但預計該公司將在三年內實現盈利，收入年增長預計為 20.3%，超過市場平均水平。然而，投資者應注意股價波動較大，預測的股本回報率為 7.8%。</p>
</div><ul>
<li>Dive into the specifics of Winning Health Technology Group here with our thorough growth forecast report.</li>
<li>Our valuation report here indicates Winning Health Technology Group may be overvalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏深入瞭解 Winning Health Technology Group 的具體情況，查看我們的詳細增長預測報告。</li>
<li>我們的估值報告顯示 Winning Health Technology Group 可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/ce106cd6-ffa6-420d-b083-2d569d2c7abb/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300253 Earnings and Revenue Growth as at Jan 2026</p>
<div class="lb-trans"><p>SZSE:300253 截至 2026 年 1 月的盈利和收入增長</p>
</div><h2>Seize The Opportunity</h2>
<div class="lb-trans"><h2>抓住機會</h2>
</div><ul>
<li>Explore the 623 names from our Fast Growing Asian Companies With High Insider Ownership screener here.</li>
<li>Curious About Other Options? Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏探索我們篩選的 623 個高內部持股快速增長的亞洲公司。</li>
<li>對其他選擇感興趣？尋找現金流潛力良好但交易價格低於其公允價值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>這篇來自 Simply Wall St 的文章具有一般性。<strong>我們提供的評論基於歷史數據和分析師預測，僅使用無偏的方法，我們的文章並不旨在提供財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。該分析僅考慮內部人士直接持有的股票，不包括通過其他工具（如公司和/或信託實體）間接持有的股票。所有引用的預測收入和收益增長率均以年化（每年）增長率的形式表示，時間範圍為 1-3 年。</em></p>
</div>

三家內部持股比例高的亞洲成長型公司